Skip to main content

The clear choice in pharmacy benefit management.

Insights Archive

spilled pills on a desk by a gavel

May 1, 2026

PBM reform is here.

ClearScript remains committed to transparency. For plan sponsors, recent federal reforms mean PBM decisions should be easier to understand and…

Adult woman holding a white pill and glass of water.

April 30, 2026

DRUG SPOTLIGHT Foundayo (orforglipron)

Foundayo is approved for use in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults…

November 17, 2025

DRUG SPOTLIGHT: Centanafadine

Centanafadine is a novel, first-in-class, non-stimulant under development for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults.  It’s rapid onset & good safety profile would likely result in uptake for patients who do not respond to generic stimulant / non-stimulant therapy options.

November 17, 2025

Your Guide to Managing Trend in 2026

If you’re managing pharmacy benefits in 2026, you’re likely facing rising costs, new therapies, and tough decisions. So how do you stay ahead? It starts with understanding what drives trend and how to manage it with confidence.

November 17, 2025

Compliance and Industry Update – November 2025

At ClearScript, we are committed to keeping you informed and prepared for the evolving landscape of Pharmacy Benefit Management (PBM). This update highlights key regulatory changes, industry updates, and ClearScript’s proactive strategies.